Joseph Kwon, MD

Dallas, TX

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3315 - Predictive Factors for Oliogometastatic Renal Cell Carcinoma Patients Treated with Stereotactic Ablative Radiation (SAbR)

  Tuesday, October 1, 2024
  2:30 PM – 3:45 PM ET